These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 1874341)
1. A natural specific intracellular ligand as a reagent for cyclosporine blood level determination. Hasková V; Rozprimová L; Svobodová J Folia Biol (Praha); 1991; 37(2):134-9. PubMed ID: 1874341 [TBL] [Abstract][Full Text] [Related]
2. Cyclophilin binding: a more accurate measure of cyclosporine immunosuppressive activity after renal transplantation. Paul K; Harding MW; Marks WH; Handschumacher RE; Lorber MI Transplant Proc; 1991 Feb; 23(1 Pt 2):974-5. PubMed ID: 1989349 [No Abstract] [Full Text] [Related]
3. Binding of active cyclosporins to cyclophilin A and B, complex formation with calcineurin A. Ryffel B; Woerly G; Murray M; Eugster HP; Car B Biochem Biophys Res Commun; 1993 Aug; 194(3):1074-83. PubMed ID: 8394698 [TBL] [Abstract][Full Text] [Related]
4. Structure of human cyclophilin and its binding site for cyclosporin A determined by X-ray crystallography and NMR spectroscopy. Kallen J; Spitzfaden C; Zurini MG; Wider G; Widmer H; Wüthrich K; Walkinshaw MD Nature; 1991 Sep; 353(6341):276-9. PubMed ID: 1896075 [TBL] [Abstract][Full Text] [Related]
5. Determination of cyclosporine by a competitive binding assay with cyclophilin. Steiner G; Küllinger B; Mayer G; Jie Y; Leibl H; Kovarik J; Woloszczuk W Clin Chem; 1991 Mar; 37(3):403-10. PubMed ID: 2004448 [TBL] [Abstract][Full Text] [Related]
6. Correlation of cyclosporine and metabolite binding to cyclophilin and a 50 kDa binding protein with in vitro immunosuppression: a preliminary report. Donnelly JG; Russell RL; Palaszynski EW; Copeland KR; Yatscoff RW; Chan MM; Soldin SJ Clin Biochem; 1991 Feb; 24(1):71-4. PubMed ID: 2060135 [TBL] [Abstract][Full Text] [Related]
7. Cyclosporine suppression of intracellular activation signal generation is not mediated by prolyl-peptidyl isomerase. Kimball PM; Kerman RH; Kahan BD Transplant Proc; 1991 Feb; 23(1 Pt 1):323-4. PubMed ID: 1990544 [No Abstract] [Full Text] [Related]
8. Peptidyl-prolyl cis-trans isomerase of Bacillus subtilis: identification of residues involved in cyclosporin A affinity and catalytic efficiency. Göthel SF; Herrler M; Marahiel MA Biochemistry; 1996 Mar; 35(11):3636-40. PubMed ID: 8639516 [TBL] [Abstract][Full Text] [Related]
9. Specific interaction between cyclophilin and cyclic peptides. Gallo P; Saviano M; Rossi F; Pavone V; Pedone C; Ragone R; Stiuso P; Colonna G Biopolymers; 1995 Sep; 36(3):273-81. PubMed ID: 7669915 [TBL] [Abstract][Full Text] [Related]
10. Immunophilins and immunosuppression by cyclosporins and macrolide structures. Schreier MH Acta Derm Venereol Suppl (Stockh); 1994; 186():100. PubMed ID: 7521103 [No Abstract] [Full Text] [Related]
11. In situ detection of cyclosporin A: evidence for nuclear localization of cyclosporine and cyclophilins. Le Hir M; Su Q; Weber L; Woerly G; Granelli-Piperno A; Ryffel B Lab Invest; 1995 Nov; 73(5):727-33. PubMed ID: 7474947 [TBL] [Abstract][Full Text] [Related]
13. Cyclosporin G and metabolite binding to cyclophilin and a 50-kDa binding protein related to in vitro immunosuppression. Donnelly JG; Chen Y; Yatscoff RW; Copeland KR; Palaszynski EW; Soldin SJ Clin Chem; 1993 Jan; 39(1):122-5. PubMed ID: 8419033 [TBL] [Abstract][Full Text] [Related]
15. A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase. Harding MW; Galat A; Uehling DE; Schreiber SL Nature; 1989 Oct; 341(6244):758-60. PubMed ID: 2477715 [TBL] [Abstract][Full Text] [Related]
16. A preliminary study to evaluate an in vitro assay for determining patient whole blood immunosuppressive cyclosporine A and metabolite activity: comparison with cytosolic binding assays using cyclophilin or a 50-kilodalton binding protein, and the Abbott TDx cyclosporine A parent, and parent and metabolites assays. Russell RL; Donnelly JG; Palaszynski EW; Chan MM; Soldin SJ Ther Drug Monit; 1991 Jan; 13(1):32-6. PubMed ID: 1829283 [TBL] [Abstract][Full Text] [Related]
17. Purification and characterization of human T-cell cyclophilin expressed in Escherichia coli. Levy MA; Brandt M; Livi GP; Bergsma DJ Transplant Proc; 1991 Feb; 23(1 Pt 1):319-22. PubMed ID: 1990542 [No Abstract] [Full Text] [Related]
18. Improved binding affinity for cyclophilin A by a cyclosporin derivative singly modified at its effector domain. Papageorgiou C; Florineth A; Mikol V J Med Chem; 1994 Oct; 37(22):3674-6. PubMed ID: 7966126 [No Abstract] [Full Text] [Related]
19. Comparison of the properties of the CsA analogs monoacetyl CyC (o-acetyl-threonine2 cyclosporin) and methyl-alanyl CsA (N-methyl-L-alanyl6 cyclosporin); monoacetyl cyclosporin is immunosuppressive without binding to cyclophilin. el Rouby S; Shi Y; Reem GH Clin Exp Immunol; 1992 Jul; 89(1):136-42. PubMed ID: 1628422 [TBL] [Abstract][Full Text] [Related]
20. Crystal structure implies that cyclophilin predominantly catalyzes the trans to cis isomerization. Zhao Y; Ke H Biochemistry; 1996 Jun; 35(23):7356-61. PubMed ID: 8652511 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]